Skip to main content
  • Offering
    • Offering
    • Integrated Biologics
      • Integrated Biologics
      • Expression Technologies
        • Expression Technologies
        • GS Xceed® Gene Expression System
        • GS piggyBac® Transposon Technology
        • GS Effex® Cell Line
        • GS Discovery® Transient Expression
        • bYlok® Bispecific Pairing Technology
        • XS Technologies®
        • Technical Support
      • Early Derisking and Optimization
        • Early Derisking and Optimization
        • Developability Assessment
        • Manufacturability Assessment
        • Antibody Humanization and Deimmunization
        • Protein Engineering
        • Potency Assessment
        • Immunogenicity / Immunotoxicity Assessment
        • Rapid Host Screen and Early Protein Expression
        • Non-GMP Manufacture
        • Epibase® in vitro and in silico Screening
      • Mammalian Biopharmaceutical Services
        • Mammalian Biopharmaceutical Services
        • Ibex® Design mAbs DNA-to-IND Program
        • Ibex® Design Bispecifics DNA-to-IND Program
        • Ibex® Design Fabs and Fc-Fusion Proteins DNA-to-IND Programs
        • Ibex® Design Scaffolds and other Recombinant Proteins
        • Cell Line Development
        • Tailored License Application Program
        • Process Development
        • Analytical Development
        • Drug Substance Manufacturing
      • Parenteral Drug Product Services
        • Parenteral Drug Product Services
        • Clinical Technology Transfers
        • Biologics Formulatability
        • Product Formulation Development
        • Analytical Development
        • Process Development
        • Biologics Special Services
        • Drug Product Manufacture
      • Biologics Regulatory Services
      • Knowledge Center
    • Advanced Synthesis
      • Advanced Synthesis
      • Small Molecules
        • Small Molecules
        • Drug Substance/API Services
          • Drug Substance/API Services
          • API Support for Early Phase Development
          • AI-Enabled Route Scouting Service
          • Solid Form Drug Services
          • PBPK Modeling Services
          • Pharmaceutical Method Development
          • Commercial API Manufacturing Services
          • Highly Potent API Technologies
            • Highly Potent API Technologies
            • HPAPI Handling and Development
            • HPAPI Manufacturing | Low & High Potency
          • ADC Clinical and Commercial Manufacturing
          • ADC Payload Product Development
        • Particle Engineering
          • Particle Engineering
          • Solid Dispersion Technology
          • Bioavailability Enhancement
          • Spray-Dried Dispersion Technology
          • Micronization and Jet Milling
          • Hot Melt Extrusion
        • Drug Product
          • Drug Product
          • SimpliFiH® Solutions
          • Drug Product Technologies
            • Drug Product Technologies
            • Specialized Drug Product Development
            • Micro-dosing for Early Human Clinical Studies
          • Clinical Trial Material Manufacture, Supply
          • Clinical Bottling, Labelling and Supply
          • Formulation and Development
          • Design and Preformulation Development
          • Drug Development Workflow & Pharmaceutical Process Optimization
          • Pediatric Drug Product Development
          • Inhalation Formulation Development
          • Integrated Offerings
        • Regulatory Affairs CMC Services
          • Regulatory Affairs CMC Services
          • CMC Development Services | CMC Regulatory Submissions
      • Bioconjugates Services
        • Bioconjugates Services
        • Early Development Bioconjugates | ADCs
        • ADC Drug Substance Manufacturing
        • Pharmaceutical, ADC Analytical Services
        • Targeting Agent and Carrier Protein
        • ADC Process Development
        • Ibex® Design ADC, DNA-to-IND Program
      • Knowledge Center
    • Specialized Modalities
      • Specialized Modalities
      • Cell & Gene
        • Cell & Gene
        • Process Development
        • cGMP Manufacturing
        • Allogeneic
        • Autologous
        • Viral Vectors
        • Exosomes
        • Cocoon® Platform
      • Microbial
        • Microbial
        • Microbial Strain Development
        • Process Development
        • Drug Substance Manufacturing
        • Analytical Development
      • mRNA/LNP
        • mRNA/LNP
        • Process Development
        • Analytical Services
        • mRNA Manufacturing
        • Lipid Nanoparticles Encapsulation
      • Bioscience Products
      • Knowledge Center
    • Knowledge Center
  • Company
    • Company
    • About Us
      • About Us
      • Our One Lonza Strategy
      • Our Leadership
        • Our Leadership
        • Executive Committee
        • Board of Directors
        • Board Committees
      • Our History
      • Our Locations
    • News and Media
      • News and Media
      • News Releases
      • Images and Videos
      • Logo Guidelines
      • Blog
      • A View On - Lonza Podcast
      • Journalist Inquiries
    • Investor Relations
      • Investor Relations
      • Shareholders and Stock Information
        • Shareholders and Stock Information
        • Consensus and Analysts
        • Bond Investors and Credit Information
        • Investor FAQ
        • Share Buyback
      • Agenda and Events
      • Reporting and Presentations
      • Corporate Governance
      • Ethics and Compliance
      • Investor Inquiries
    • Sustainability
      • Sustainability
      • Environment
      • People and Society
      • Compliance and Integrity
      • Responsible Sourcing
      • Global Quality
  • Careers
    • Careers
    • Welcome to Lonza
    • Life at Lonza
    • Employee Benefits
    • Early Career Opportunities
    • Inclusion, Diversity and Belonging
    • Join Our Talent Community
  • Contact Search
  • Cancel

Restored archive imagery

Lonza began making nitric acid for fertilizers in 1927
Lonza’s facilities expanded in the Valais as the business continued to develop in the first half of the Twentieth Century
Lonza produced hydroelectricity from the River Lonza
Lonza’s early beginnings in the Swiss Alps
Lonza’s second site in Visp
Lonza’s hydroelectricity power station in Gampel
A sorting facility for fertilizer in Gampel
At times, fertilizer bags were stacked up to 40 levels high
Reckingen Kraftwerk was a low-pressure hydroelectric power plant in a shallow section of the Rhine, which was completed in 1942
Early workers at Lonza, est.1915
Lonza’s first shipment of Acetic acid, an important chemical reagent
In the 1930s and 40s, Lonza developed sophisticated products for specific crops
An early image of Lonza’s site in Gampel, adjacent to the River Lonza
Lonza’s exhibited fertilizers at industry events, such as this one in Lausanne est. 1933
Hydroelectricity was a major source of power in the early Twentieth Century and remains a major source of renewable energy in Switzerland today
Lonza’s first site in Gampel was adjacent to the River Lonza, after which the company is named
For 125 years, Lonza’s people have adapted to work with new technology and innovations
Lonza’s pioneering approach to technological innovation has been a major driver of competitive advantage
The construction of large dams helped to harness hydropower, a major source of electricity in Switzerland in the Twentieth Century
Lonza’s fertilizers supported food security in Switzerland during the wartime years
A Lonza worker monitoring the manufacturing facility
Alfons Ehinger, the first President of Lonza
Lonza was established to harness the hydroelectric power of the River Lonza for the manufacture of calcium carbide
Lonza built hydroelectric plants in the Swiss valleys in the late 1800s
Large, heavy and industrial goods were often moved by rail
By the mid-Twentieth Century, Lonza was a major player in chemical manufacture
Lonza’s site in Gampel used energy from hydropower to produce calcium carbide, a critical source of light at the turn of the Twentieth Century
An early look inside Lonza’s Gampel hydropower facility
Lonza Gampel, 1916
Colleagues producing carbide in Gampel, 1916
An early image of Lonza’s first site in Gampel, est. 1899
A component for the construction of the Reckingen hydropower plant, 1941
Visp, 1909
Fertilizer production in the 1930s
Who we are
  • Company Overview
  • News & Media
  • Investor Relations
  • Sustainability
  • Careers
Quick Links
  • Reporting Center
  • Upcoming Events
  • Knowledge Center
  • Meet The Experts
  • Site Tours
  • California CCPA Notice
  • Transparency in Coverage
Get in touch
  • Contact Us
  • Regulatory Support
© 2025 Lonza. All rights reserved.
Cookie Settings | Terms and Conditions | Legal Disclaimer | Privacy Policy